Document is current
Any future updates will be listed below
-
Authors
Kullmann, Stephanie https://orcid.org/0000-0001-9951-923X
Wagner, Lore https://orcid.org/0000-0002-8868-9281
Hauffe, Robert
Kühnel, Anne https://orcid.org/0000-0003-3066-3801
Sandforth, Leontine
Veit, Ralf https://orcid.org/0000-0001-9860-642X
Dannecker, Corinna
Machann, Jürgen https://orcid.org/0000-0002-4458-5886
Fritsche, Andreas
Stefan, Nobert
Preissl, Hubert https://orcid.org/0000-0002-8859-4661
Kroemer, Nils B. https://orcid.org/0000-0002-9552-3781
Heni, Martin https://orcid.org/0000-0002-8462-3832
Kleinridders, André https://orcid.org/0000-0002-4248-6366
Birkenfeld, Andreas L. https://orcid.org/0000-0003-1407-9023
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925, 01GI0925)
German Center for Diabetes Research
- License Information
-
More Information
Article History
Received: 15 April 2024
Accepted: 30 January 2025
First Online: 21 February 2025
Competing interests
: M.H. reports research grants from Boehringer Ingelheim and Sanofi to the University Hospital of Tübingen; participation in advisory board for Boehringer Ingelheim, Sanofi and Amryt; and lecture fees from Amryt, Novartis, Sanofi, Eli Lilly, Novo Nordisk and Boehringer Ingelheim. The other authors declare no competing interests.
